81 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
officers is one designed to reward achievement of individual and corporate objectives; provide for short-, medium- and long-term financial … ) participation in equity-based long-term incentive compensation plans generally available to senior executive officers of the Company (beginning in 2025); and (v
8-K
EX-99.1
5rjxuuy7a9zwgocvc0qk
8 Aug 23
Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer
10:30am
8-K
EX-10.1
e7m96mece cnkqvjlci
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
424B5
en6geb3 t2e4x5
24 Mar 22
Prospectus supplement for primary offering
4:15pm
424B5
m1wym
20 Aug 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-1.1
we527 69ypaapoy
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm